The sustainability of the Cancer Drugs Fund

The Pharmaceutical Journal held a panel discussion on the value of medicine at the RPS annual conference in Birmingham on 14 September 2015. Elizabeth Sukkar, the journal’s deputy news editor, asks key opinion leaders from NICE, the ABPI, the NHS and Myeloma UK on the sustainability of the Cancer Drugs Fund considering it is massively over budget. Read more about the panel discussion here

Last updated
Citation
The Pharmaceutical Journal, October 2015;Online:DOI:10.1211/PJ.2015.20069492